» Articles » PMID: 17301206

Multifaceted Implementation of Stroke Prevention Guidelines in Primary Care: Cluster-randomised Evaluation of Clinical and Cost Effectiveness

Overview
Specialty Health Services
Date 2007 Feb 16
PMID 17301206
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate clinical and cost effectiveness of implementing evidence-based guidelines for the prevention of stroke.

Design: Cluster-randomised trial

Setting: Three primary care organisations in the North of England covering a population of 400,000.

Participants: Seventy six primary care teams in four clusters: North, South & West, City I and City II.

Intervention: Guidelines for the management of patients with atrial fibrillation and transient ischaemic attack (TIA) were developed and implemented using a multifaceted approach including evidence-based recommendations, audit and feedback, interactive educational sessions, patient prompts and outreach visits.

Outcomes: Identification and appropriate treatment of patients with atrial fibrillation or TIA, and cost effectiveness.

Results: Implementation led to 36% increase (95% CI 4% to 78%) in diagnosis of atrial fibrillation, and improved treatment of TIA (odds ratio of complying with guidelines 1.8; 95% CI 1.1 to 2.8). Combined analysis of atrial fibrillation and TIA estimates that compliance was significantly greater (OR 1.46 95% CI 1.10 to 1.94) in the condition for which practices had received the implementation programme. The development and implementation of guidelines cost less than 1500 pounds per practice. The estimated costs per quality-adjusted life year gained by patients with atrial fibrillation or TIA were both less than 2000 pounds, very much less than the usual criterion for cost effectiveness.

Conclusions: Implementation of evidence-based guidelines improved the quality of primary care for atrial fibrillation and TIA. The intervention was feasible and very cost effective. Key components of the model include contextual analysis, strong professional support, clear recommendations based on robust evidence, simplicity of adoption, good communication and use of established networks and opinion leaders.

Citing Articles

What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? A scoping review.

Heggie R, Boyd K, Kamaruzaman H, Wu O Health Res Policy Syst. 2024; 22(1):134.

PMID: 39350148 PMC: 11441006. DOI: 10.1186/s12961-024-01220-9.


Audit as a Tool for Improving the Quality of Stroke Care: A Review.

Cappadona I, Corallo F, Cardile D, Ielo A, Bramanti P, Lo Buono V Int J Environ Res Public Health. 2023; 20(5).

PMID: 36901501 PMC: 10002159. DOI: 10.3390/ijerph20054490.


Supporting anticoagulant treatment decision making to optimise stroke prevention in complex patients with atrial fibrillation: a cluster randomised trial.

Gattellari M, Hayen A, Leung D, Zwar N, Worthington J BMC Fam Pract. 2020; 21(1):102.

PMID: 32513116 PMC: 7281948. DOI: 10.1186/s12875-020-01175-0.


Estimating Costs of Implementing Stroke Systems of Care and Data-Driven Improvements in the Paul Coverdell National Acute Stroke Program.

Yarnoff B, Khavjou O, Elmi J, Lowe-Beasley K, Bradley C, Amoozegar J Prev Chronic Dis. 2019; 16:E134.

PMID: 31580797 PMC: 6795072. DOI: 10.5888/pcd16.190061.


Local opinion leaders: effects on professional practice and healthcare outcomes.

Flodgren G, OBrien M, Parmelli E, Grimshaw J Cochrane Database Syst Rev. 2019; 6:CD000125.

PMID: 31232458 PMC: 6589938. DOI: 10.1002/14651858.CD000125.pub5.


References
1.
. Medical audit in general practice. I: Effects on doctors' clinical behaviour for common childhood conditions. North of England Study of Standards and Performance in General Practice. BMJ. 1992; 304(6840):1480-4. PMC: 1882231. DOI: 10.1136/bmj.304.6840.1480. View

2.
. Royal College of Physicians of Edinburgh Consensus Conference on Medical Management of Stroke, 26-27 May 1998. Age Ageing. 1999; 27(6):665-6. DOI: 10.1093/ageing/27.6.665. View

3.
Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M . When is it cost-effective to change the behavior of health professionals?. JAMA. 2001; 286(23):2988-92. DOI: 10.1001/jama.286.23.2988. View

4.
Eckman M, LEVINE H, Salem D, Pauker S . Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1998; 114(5 Suppl):699S-714S. DOI: 10.1378/chest.114.5_supplement.699s. View

5.
GRESHAM G, Alexander D, Bishop D, Giuliani C, Goldberg G, Holland A . American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Rehabilitation. Stroke. 1997; 28(7):1522-6. DOI: 10.1161/01.str.28.7.1522. View